Clinical Trial: Using Fluorine-18-Labeled Fluoro-Misonidazole Positron Emission Tomography To Detect Hypoxia in Head and Neck Cancer Patients
Clinical Trial: Using Fluorine-18-Labeled Fluoro-Misonidazole Positron Emission Tomography To Detect Hypoxia in Head and Neck Cancer PatientsSponsor and Collaborators
Memorial Sloan-Kettering Cancer Center
Contact
Contact: Nancy Lee, MD
212-639-3341
Contact: Heiko Schoder, MD
212-639-2079
Principal Investigator
Nancy Lee, MD Memorial Sloan-Kettering Cancer Center
ClinicalTrials.gov Identifier
NCT00606294
